Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2005
07/19/2005US6919313 Amino acid sequences for use in the treatment of inflammation and autoimmune diseases
07/19/2005US6919312 Polysaccharides
07/19/2005US6919311 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII
07/19/2005US6919309 Methods and compositions for inhibiting angiogenesis
07/19/2005US6919308 Comprising a matrix containing pure natural-sourced mammalian osteogenic protein
07/19/2005US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
07/19/2005US6919206 Medium containing flt3 ligand for culturing hematophoietic cells
07/19/2005US6919204 Modulation of gene expression using localization domains
07/19/2005US6919203 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
07/19/2005US6919196 Parvovirus NS1 variants
07/19/2005US6919193 Comprises nucleotide sequences for detecting protein factors; forensics; genetic mapping; evaluating biodiversity
07/19/2005US6919187 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines
07/19/2005US6919186 Fluorescent proteins
07/19/2005US6919183 Detecting and isolating cells that produce preferential protein; obtain cells, transfrom cells with vector containing preferential protein, detect protein on surface of cell, isolate cells displaying preferential protein
07/19/2005US6919177 Screening animal for preferential meat qualities; obtain tissue sample, extract nucleotide sequences, detect geneotype associated with litter size, screen for polymorphism
07/19/2005US6919176 Polypeptides and nucleic acids associated with cancer
07/19/2005US6919086 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same
07/19/2005US6919085 E2 subunit vaccine comprising recombinant pestivirus E2 protein
07/19/2005US6919083 Fish vaccine
07/19/2005US6919080 Polypeptide for use in the treatment of respiratory disorders in poultry
07/19/2005US6919078 Antibodies to human tumor necrosis factor receptor TR9
07/19/2005US6919075 Bacteriophage displaying aβ epitopes and method of use
07/19/2005US6919070 Stomatic composition
07/19/2005CA1341486C Modified protein a
07/14/2005WO2005064021A2 Vaccine
07/14/2005WO2005064005A1 A method for obtaining solid tumor-related floating protein in blood
07/14/2005WO2005064001A2 Process for preparing l-amino acids using strains of the enterobacteriaceae family
07/14/2005WO2005064000A1 Process for preparing l-amino acids using strains of the enterobacteriaceae family
07/14/2005WO2005063998A2 Maize metallothionein 2 promoter and methods of use
07/14/2005WO2005063997A2 Maize metallothionein promoter
07/14/2005WO2005063996A2 Plant activation of insect toxin
07/14/2005WO2005063994A1 Puroindoline-a inducible promoter
07/14/2005WO2005063992A1 Novel serum type streptococcus mutans and utilization of the same
07/14/2005WO2005063991A2 Live genetically attenuated malaria vaccine
07/14/2005WO2005063990A2 Wuschel (wus) gene homologs
07/14/2005WO2005063987A1 Gp153: methods and compositions for treating cancer
07/14/2005WO2005063986A1 Immune response regulatory protein
07/14/2005WO2005063820A2 Il-7 fusion proteins
07/14/2005WO2005063814A1 Process for purification of hemoglobin
07/14/2005WO2005063813A2 Process for the production of tumor necrosis factor-binding proteins
07/14/2005WO2005063812A2 Cc-chemokine-binding tick proteins
07/14/2005WO2005063811A1 Method for purifying fsh
07/14/2005WO2005063810A1 Isolated cytotoxic factor associated with multiple sclerosis and method of detecting said cytotoxic factor
07/14/2005WO2005063809A1 Nature-identical erythropoietin
07/14/2005WO2005063808A1 Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS
07/14/2005WO2005063807A2 Treatment of coronary or peripheral ischemia
07/14/2005WO2005063806A1 Arginine hydrochloride enhances chaperone-like activity of alpha crystallin
07/14/2005WO2005063805A1 Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection
07/14/2005WO2005063804A1 Compounds useful in the diagnosis and treatment of malaria
07/14/2005WO2005063803A1 Polypeptides for the diagnosis and therapy of leishmaniasis
07/14/2005WO2005063802A2 Haemophilus influenzae type iv pili
07/14/2005WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
07/14/2005WO2005063800A2 Peptide synthesis using decanting filter
07/14/2005WO2005063799A2 Peptide synthesis and deprotection with co-solvent
07/14/2005WO2005063798A1 Identification of two linear epitopes on ebola or marburg virus glycoproteins critical for infection
07/14/2005WO2005063796A1 Inhibitors of amyloid precursor protein processing
07/14/2005WO2005063794A1 A process for the preparation and purification of recombinant proteins
07/14/2005WO2005063793A1 Process and systems for recovery of peptides
07/14/2005WO2005063792A2 Methods for recovering cleaved peptide from a support
07/14/2005WO2005063302A1 Drug for preventing or treating heart diseases comprising cd9 gene
07/14/2005WO2005063301A1 Emt inducer
07/14/2005WO2005063299A2 Compositions and methods for the treatment of tumor of hematopoietic origin
07/14/2005WO2005063292A2 Heh4 molecules and uses thereof
07/14/2005WO2005063290A2 Use of il-18 binding protein in inflammations
07/14/2005WO2005063285A1 The sesl vaccine
07/14/2005WO2005063282A1 Anti-retroviral agents, compositions, methods and uses
07/14/2005WO2005063279A1 Means for stimulation and activation of hair growth by il-15
07/14/2005WO2005062947A2 Methods and compositions for identifying rna-binding proteins
07/14/2005WO2005062942A2 Novel oligonucleotides and treating cardiac disorders by using the same
07/14/2005WO2005062871A2 Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays
07/14/2005WO2005062864A2 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent
07/14/2005WO2005062767A2 Hoxd3, hoxa3, and hoxb3 compositions and methods for improved wound healing
07/14/2005WO2005056043A3 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
07/14/2005WO2005053505A3 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis
07/14/2005WO2005038034A3 Plant transcriptional regulators of abiotic stress
07/14/2005WO2005033274A3 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
07/14/2005WO2005021583A3 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β
07/14/2005WO2005014828A3 Process for the production of fine chemicals in plants
07/14/2005WO2005014822A3 Novel therapeutic fusion proteins
07/14/2005WO2005012481A3 Non-immunoglobulin binding polypeptides
07/14/2005WO2005012350A3 Epha2 t-cell epitope agonists and uses therefor
07/14/2005WO2005003165A3 Cytokine variant polypeptides
07/14/2005WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor
07/14/2005WO2004113374A3 Chlamydia pneumoniae antigens
07/14/2005WO2004111084A3 Peptides enhancing ceh activity or inhibiting acat activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis
07/14/2005WO2004108765A3 Extracellular aspergillus polypeptides
07/14/2005WO2004101747A3 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
07/14/2005WO2004096849A3 Peptide-based cytokine/chemokine vaccines against allergy
07/14/2005WO2004085475A3 Anti-il-20 antibodies and binding partners and methods of using in inflammation
07/14/2005WO2004078939A3 REGULATION OF Mdm2 FUNCTION
07/14/2005WO2004063340A3 Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061,17662,1468,12282, 6350, 9035,1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123,12788,17729, 65552,1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 4
07/14/2005WO2004060270A8 Compositions and methods for the diagnosis and treatment of tumor
07/14/2005WO2004056855A9 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
07/14/2005WO2004031211A8 Hla binding peptides and their uses
07/14/2005WO2003029424A3 Novel proteins and nucleic acids encoding same
07/14/2005WO2002072793A3 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor
07/14/2005US20050155112 Insecticidal protein for use as tool in preventing and controlling corn root worm infestation; biological pest control
07/14/2005US20050155110 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhamced shelf life
07/14/2005US20050155108 Maize cellulose synthases and uses thereof
07/14/2005US20050155105 Increasing salt tolerance in plants by overexpression of vacuolar Na+/H+ transporters